ELEISON RECENT NEWSMay 6, 2014 Mr. Timothy Whitten Joins Eleison Pharmaceuticals Board of DirectorsJanuary 3, 2014 Eleison Announces Achievement of Enrollment Milestone in its Phase II Trial of ILC for Pediatric Bone Cancer October 8, 2013 ILC Granted Orphan Drug Designation in Europe for the Treatment of OsteosarcomaSITEMAP RESOURCES Eleison Pharmaceuticals, LLC.Osteosarcoma Clinical Trials SlideshowOsteosarcoma Clinical Trials Video About Eleison PharmaceuticalsCompany NewsCareer OpportunitiesContact